Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Select Medical Holdings (SEM) EBT (2018 - 2026)

Select Medical Holdings (SEM) has disclosed EBT for 9 consecutive years, with $82.1 million as the latest value for Q1 2026.

  • For Q1 2026, EBT fell 14.65% year-over-year to $82.1 million; the TTM value through Mar 2026 reached $258.7 million, up 41.54%, while the annual FY2025 figure was $272.7 million, 56.06% up from the prior year.
  • EBT hit $82.1 million in Q1 2026 for Select Medical Holdings, up from $50.5 million in the prior quarter.
  • Across five years, EBT topped out at $96.2 million in Q1 2025 and bottomed at -$179.0 million in Q4 2022.
  • Average EBT over 5 years is $41.4 million, with a median of $54.3 million recorded in 2022.
  • Year-over-year, EBT crashed 410.42% in 2022 and then soared 558.83% in 2024.
  • Select Medical Holdings' EBT stood at -$179.0 million in 2022, then soared by 119.48% to $34.9 million in 2023, then tumbled by 142.85% to -$14.9 million in 2024, then skyrocketed by 437.71% to $50.5 million in 2025, then soared by 62.68% to $82.1 million in 2026.
  • According to Business Quant data, EBT over the past three periods came in at $82.1 million, $50.5 million, and $55.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.